Episode 88

For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress

Featuring perspectives from Dr Beth Faiman, Dr Natalie S Callander, Dr Hans Lee and Dr Mary Steinbach, moderated by Dr Callander, including the following topics:

  • Introduction (00:00)
  • Role of Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory (R/R) MM (3:44)
  • Role of BCMA- and Non-BCMA-Targeted Bispecific Antibodies in R/R MM (27:00)
  • Utility of Belantamab Mafodotin in R/R MM (49:29)
  • Potential Role of Cereblon E3 Ligase Modulators in MM (1:07:01)

CME information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Hematologic Oncology Update
Hematologic Oncology Update
This series bridges the gap between research and patient care by providing medical oncologists with access to important information on relevant advances in the treatment of hematologic malignancies.

Listen for free